Rick Doblin – Latest Developments In Psychedelic Science From MAPS

A discussion of the latest developments in MAPS’ e ort to conduct research will focus on the aim to develop MDMA- assisted psychotherapy into EMA and FDA approved prescription treatment. Also covered in this talk: MAPS’ marijuana study for chronic, treatment resistant PTSD, an observational study involving US Veterans with PTSD receiving Ayahuasca in Peru, and our Psychedelic Harm Reduction work. The big picture is the overall importance of psychedelic research and cultural evolution.

Filmed at Breaking Convention 2017 in the UK.

Source: Youtube